How to Choose the Packaging for Eye Drop Bottles


Release Date:

2026-01-20

The selection of eye-drop bottle packaging must center on three core requirements: stability of the drug solution, sterility assurance, and ease of use, while also ensuring medical compliance and patient safety. Specific considerations are as follows: Prioritize materials that are compatible with the characteristics of the drug solution. Since eye-drop bottles come into direct contact with the drug solution, the material must exhibit high chemical stability—no reaction with the solution and no leaching of harmful substances. Commonly used medical-grade materials include: Low-density polyethylene (LDPE): Soft and easy to squeeze, moderately priced, and chemically stable; suitable for most aqueous eye drops such as artificial tears and antibiotic eye drops. However, its barrier properties are relatively weak, making it unsuitable for oxidizable formulations. High-density polyethylene (HDPE): Harder and more puncture-resistant, with superior barrier properties compared with LDPE; ideal for preservative-containing eye drops or formulations requiring long-term storage. Polypropylene (PP): Excellent temperature resistance, capable of withstanding steam sterilization, and highly chemically inert; suitable for specialized eye drops containing acidic or alkaline ingredients or those prone to hydrolysis. It can also be manufactured into rigid, graduated bottles for precise dose control. Polyester (PET): Outstanding barrier properties, effectively blocking oxygen and moisture; well-suited for oxidizable eye drops such as vitamin-based and hormone-based formulations. Often produced in single-use, small-volume vials (1–2 mL) to minimize contamination from repeated use. Contraindication: Avoid using polyvinyl chloride (PVC), as its plasticizers may migrate into the drug solution and cause ocular irritation. Strengthen the sterile barrier and anti-contamination design. Given the fragility of the ocular mucosa, eye drops must remain sterile throughout their entire lifecycle, so the packaging design must meet the following requirements: Sealing structure: Employ a double-seal system consisting of a screw cap and an inner stopper. The inner stopper should preferably be made of medical-grade silicone, offering excellent sealing performance and good compatibility with the drug solution to prevent leakage or microbial ingress during transport. Single-use vs. multi-use: Preservative-free eye drops should be packaged in single-use, small-volume containers (daily-disposable type) and used immediately after opening; preservative-containing eye drops may be offered in larger-volume bottles, but the post-opening shelf life must be clearly labeled (typically no more than 4 weeks). Sterilization compatibility: The packaging material must withstand ethylene oxide or gamma-ray sterilization without leaving toxic residues, thereby ensuring the sterility of the drug solution inside the bottle. Balance convenience and safety in use. The packaging design should align with patients’ habitual usage patterns to reduce operational risks: Bottle design: Rigid bottles should have a non-slip surface, while flexible bottles should be easy to squeeze and possess good resilience to prevent over-dosing due to excessive force; the bottle mouth should be smooth and rounded to avoid scratching the eyelid. Light protection: For photosensitive drugs such as B vitamins and levofloxacin, brown or opaque materials should be selected, or the bottle should be paired with a light-protective outer box to prevent photodegradation and loss of efficacy. Clear labeling: The bottle must clearly display information such as the drug name, concentration, expiration date, post-opening shelf life, and storage conditions, with legible, easy-to-read fonts. Compliance with medical packaging standards. The packaging must comply with the Chinese Pharmacopoeia and the YBB series standards for pharmaceutical packaging materials, pass biocompatibility testing (no sensitization or irritation), and meet the registration requirements of the National Medical Products Administration, ensuring that both the materials and design adhere to medical-grade specifications.

The selection of packaging for eye-drop bottles should be centered on three core requirements: formulation stability, sterility assurance, and ease of use, while also taking into account regulatory compliance and patient safety. Specific considerations are as follows:
Prioritize materials that are compatible with the characteristics of the medicinal solution.
Since the eye-drop bottle is in direct contact with the medicinal solution, the material must exhibit high chemical stability—remaining chemically inert and not leaching harmful substances. Commonly used medical-grade materials include the following:
Low-density polyethylene (LDPE): soft and easy to extrude, moderately cost-effective, with good chemical stability; suitable for most aqueous ophthalmic solutions (such as artificial tears and antibiotic eye drops), but with relatively poor barrier properties, making it unsuitable for oxidizable formulations.
High-density polyethylene (HDPE): exhibits higher hardness and superior puncture resistance, with better barrier properties than LDPE, making it suitable for preservative-containing ophthalmic solutions or formulations requiring long-term storage.
Polypropylene (PP): exhibits excellent thermal resistance, is suitable for steam sterilization, and is chemically inert, making it ideal for special ophthalmic solutions containing acidic or alkaline ingredients or those prone to hydrolysis. Additionally, PP can be molded into rigid vials with graduated markings, facilitating precise dose control.
Polyester (PET): Exhibits excellent barrier properties, effectively preventing the permeation of oxygen and water vapor, making it suitable for oxidative-sensitive ophthalmic solutions such as vitamin and hormone formulations. It is often manufactured into single-use, small-volume vials (1–2 mL) to minimize contamination from repeated use.
Contraindication: Avoid using polyvinyl chloride (PVC) materials, as their plasticizers may migrate into the medicinal solution and cause ocular irritation.
Strengthening the Sterile Barrier and Contamination Prevention Design
The ocular mucosa is delicate, so eye drops must remain sterile throughout the entire process, and the packaging design must meet the following requirements:
Sealing Structure: A double-layer seal is employed, consisting of a screw cap and an inner plug. The inner plug is preferably made of medical-grade silicone, offering excellent sealing performance and good compatibility with the pharmaceutical solution to prevent leakage or microbial contamination during transportation.
Single-use vs. multi-use: Preservative-free eye drops must be packaged in single-use, small-volume containers (daily-disposable format) and used immediately after opening; preservative-containing eye drops may be available in larger bottles, but the post-opening shelf life must be clearly labeled (typically no more than 4 weeks).
Sterilization compatibility: The packaging material must be resistant to ethylene oxide or gamma-ray sterilization and must not leave behind any toxic residues after sterilization, thereby ensuring that the drug solution inside the vial remains sterile.
Balancing ease of use with security
Packaging design should align with patients’ usage habits to reduce operational risks:
Bottle design: Rigid bottles should be non-slip, while flexible bottles should be easy to squeeze and have good resilience to prevent excessive medication from being dispensed due to overpressure; the bottle opening should be smooth and rounded to avoid scratching the eyelid.
Light-protected storage requirements: For photosensitive solutions such as B vitamins and levofloxacin, use brown or opaque containers, or supplement with light-protective outer packaging, to prevent photodegradation and loss of potency.
Clear labeling: The bottle must be labeled with the name of the medicinal solution, its concentration, expiration date, shelf life after opening, storage conditions, and other relevant information, using clear, easy-to-read font.
Complies with medical packaging compliance standards
Compliance with the Chinese Pharmacopoeia and the YBB series standards for pharmaceutical packaging materials is required, along with biocompatibility testing (no sensitization, no irritation), as well as fulfillment of the registration requirements of the National Medical Products Administration, to ensure that the packaging materials and design meet medical-grade specifications.

Return to list